Soc. Generale Knock-Out iShares N.../ DE000SQ3VT51 /
2024-05-28 3:43:20 PM | Chg.-0.080 | Bid4:07:50 PM | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
5.150EUR | -1.53% | 5.100 Bid Size: 35,000 |
- Ask Size: - |
- | 79.1224 USD | 2078-12-31 | Call |
GlobeNewswire
2:00 PM
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
GlobeNewswire
2:00 PM
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
GlobeNewswire
2:00 PM
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
GlobeNewswire
2:00 PM
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire
2:00 PM
HiberCell Announces First Patient Dosed in Phase 1b Clinical Trial, Evaluating HC-7366 in Combinatio...
GlobeNewswire
1:35 PM
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
GlobeNewswire
1:30 PM
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
1:30 PM
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
1:10 PM
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
GlobeNewswire
1:03 PM
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 a...
GlobeNewswire
1:02 PM
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
GlobeNewswire
1:00 PM
Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
GlobeNewswire
12:59 PM
Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer ...
GlobeNewswire
12:24 PM
Urteste has successfully developed a prototype urine-based diagnostic test for detecting brain tumou...
GlobeNewswire
9:00 AM
TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024